Veterans’ RightsAn independent resource for veterans
← All decisions
Remanded (sent back)

The Board has remanded the case due to new evidence received after the September 2020 Supplemental Statement of the Case. The claim for an evaluation in excess of 30 percent for keratosis pilaris, folliculitis, and melasma will be reconsidered.

The deciding factor: New medical evidence was added to the record since the last SSOC, necessitating a remand for readjudication.

Claimed conditions
keratosis pilaris, folliculitis, melasma
How they argued it
Direct service connection
Exposure basis
None
Rating
Not verified here — check the original decision
Decision date
July 27, 2023
Citation
23041144

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 23041144.

What this means for you

A remand sends an issue back for more development, often a new examination or missing records. It does not award the benefit or decide the final outcome. The original decision explains the additional work ordered.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.